Arvee Laboratories Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 9, 2026
- Posted by: Harsh Piplani
- Category: Results
Arvee Laboratories share price Rs 221.50 on 9 September 2026, up 14.33%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 1.69 crore. Q2 FY26 base a profit of Rs 0.01 crore.
Quick Answer
The Arvee Laboratories Q2 results date for FY27 is not confirmed, and Arvee Laboratories (India) Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 3.45 crore in revenue and a profit of Rs 0.01 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Arvee Laboratories Q2 results FY27 announcement is the next scheduled earnings event for Arvee Laboratories (India) Ltd., a small Gujarat specialty chemicals maker producing polymer modifiers along with contrast media and drug intermediates for pharmaceutical and chemical customers. The stock traded at Rs 221.50 on the NSE on 9 September 2026, up 14.33% from the previous close of Rs 193.74, about 23.8% below its 52-week high of Rs 290.78 and 71.6% above its 52-week low of Rs 129.11.
What makes the Arvee Laboratories Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 3.45 crore of revenue and a profit of Rs 0.01 crore, while the most recent quarter on record, Q1 FY27, produced Rs 17.23 crore and a profit of Rs 1.69 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Arvee Laboratories Q2 Results FY27 Date?
The Arvee Laboratories Q2 results date for FY27 is not confirmed. As of 9 September 2026, Arvee Laboratories (India) Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Arvee Laboratories Q2 results date becomes public through that filing rather than through any advance announcement.
The Arvee Laboratories Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Arvee Laboratories.
Arvee Laboratories Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Arvee Laboratories Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Arvee Laboratories. The Arvee Laboratories Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is the September 2025 base, which was the weakest quarter in the table. Revenue collapsed to Rs 3.45 crore with a 3.48% operating margin and a profit of Rs 0.01 crore, so any year-on-year growth figure will look extreme off that number.
The second is the scale of the recovery since. Revenue reached Rs 17.23 crore in Q1 FY27 at a 14.45% operating margin, the best quarter in the visible record on every line, with a normal tax charge behind it.
The third is that the December 2025 profit of Rs 1.83 crore exceeded pre-tax profit of Rs 1.40 crore because of a tax credit. That quarter’s earnings per share is inflated and should not anchor a comparison.
Check Arvee Laboratories (India) Ltd. Live Fundamentals on the Univest Screener
Arvee Laboratories Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Arvee Laboratories (India) Ltd. reported revenue of Rs 17.23 crore in Q1 FY27, up 130.35% from Rs 7.48 crore in Q1 FY26, and a profit of Rs 1.69 crore at the net level, up 894.12% from Rs 0.17 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was up 59.54% over the March 2026 quarter figure of Rs 10.80 crore, and net profit was up 225.00% from Rs 0.52 crore in Q4 FY26. Operating margin stood at 14.45% in Q1 FY27 against 3.48% in the September 2025 quarter, which is the comparison the Arvee Laboratories Q2 results print will be read against.
Q2 FY26 Base: The Comparison Arvee Laboratories Q2 Results FY27 Must Beat
Arvee Laboratories (India) Ltd. reported revenue of Rs 3.45 crore and a profit of Rs 0.01 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Arvee Laboratories Q2 results preview.
Net profit in that base quarter was below the Rs 1.69 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 3.45 crore sits below the Rs 17.23 crore of the June 2026 quarter, which frames how much sequential movement the Arvee Laboratories Q2 results print needs to show growth.
Arvee Laboratories Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 3.45 | 0.01 |
| Q3 FY26 (Dec 2025) | 9.78 | 1.83 |
| Q4 FY26 (Mar 2026) | 10.80 | 0.52 |
| Q1 FY27 (Jun 2026) | 17.23 | 1.69 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Arvee Laboratories Q2 results preview uses.
Revenue across those four quarters ranged from Rs 3.45 crore to Rs 17.23 crore, and net profit from Rs 0.01 crore to Rs 1.83 crore. That spread is the honest context for the Arvee Laboratories Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Arvee Laboratories Q2 Results FY27
The Arvee Laboratories Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Arvee Laboratories has already reported.
Very Small Revenue Base
Quarterly revenue between Rs 3.45 crore and Rs 17.23 crore means a single order changes the picture entirely. Percentage growth measures against the September 2025 quarter will be arithmetically large without saying much.
Polymer Modifiers and Pharma Intermediates
The two product lines serve different customers and carry different margins, so the mix in any quarter explains the swing between a 3.48% and a 16.67% operating margin better than volume does.
Sharp Move Into the Print
The shares are up 14.33% on the day at Rs 221.50 against a 50-day average of Rs 164.68, with a 14-day RSI of 76.22, and trade at 7.21 times a book value of Rs 30.70. The company is effectively debt-free.
Arvee Laboratories Q2 Results FY27: Share Price and Valuation Going Into the Print
Arvee Laboratories share price today is Rs 221.50 on the NSE, up Rs 27.76 or 14.33% from the previous close of Rs 193.74 on 9 September 2026, ahead of the Arvee Laboratories Q2 results announcement.
| Metric | Value (9 September 2026) |
|---|---|
| NSE Symbol | ARVEE |
| Current Market Price | Rs 221.50 |
| 52-Week High | Rs 290.78 |
| 52-Week Low | Rs 129.11 |
| Market Capitalisation | Rs 244.34 crore |
| PE Ratio | 60.17 |
| PB Ratio | 7.21 |
| EPS (TTM) | Rs 3.68 |
| Book Value per Share | Rs 30.70 |
| Debt to Equity | 0.03 |
| Return on Equity | 7.78% |
| 50-Day Moving Average | Rs 164.68 |
| 200-Day Moving Average | Rs 168.76 |
| RSI (14) | 76.22 |
The stock trades above both its 50-day average of Rs 164.68 and its 200-day average of Rs 168.76, with a 14-day RSI of 76.22. None of this is a view on where the shares go once the Arvee Laboratories Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Arvee Laboratories (India) Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Arvee Laboratories Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Arvee Laboratories Q2 results print in proportion.
- Revenue against the Rs 3.45 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 0.01 crore in that same quarter
- Operating margin against 14.45% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Arvee Laboratories Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Arvee Laboratories Q2 Results FY27
The Arvee Laboratories Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Arvee Laboratories (India) Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Arvee Laboratories Q2 results FY27 print faces a base of Rs 3.45 crore in revenue and a profit of Rs 0.01 crore, with the most recent quarter having delivered Rs 17.23 crore and a profit of Rs 1.69 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Arvee Laboratories, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Arvee Laboratories Q2 Results FY27
What is the Arvee Laboratories Q2 results date for FY27?
Ans. The Arvee Laboratories Q2 results date for FY27 is not confirmed. Arvee Laboratories (India) Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Arvee Laboratories Q2 results 2026 cover?
Ans. The Arvee Laboratories Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Arvee Laboratories (India) Ltd. reports revenue, operating profit and net profit for that period, and the Arvee Laboratories Q2 results filing also carries the notes to the accounts.
What were the Arvee Laboratories Q1 FY27 results?
Ans. Arvee Laboratories (India) Ltd. reported revenue of Rs 17.23 crore in Q1 FY27 and a profit of Rs 1.69 crore at the net level. Revenue was up 130.35% versus Q1 FY26 and net profit was up 894.12% from Rs 0.17 crore in Q1 FY26.
What were Arvee Laboratories Q2 FY26 results in the September 2025 quarter?
Ans. Arvee Laboratories (India) Ltd. reported revenue of Rs 3.45 crore and a profit of Rs 0.01 crore in Q2 FY26. Operating margin was 3.48%. Those figures form the base for the Arvee Laboratories Q2 results FY27 comparison.
What are the main Arvee Laboratories Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Arvee Laboratories Q2 results expectations centre on revenue against the Rs 3.45 crore base, net profit against a profit of Rs 0.01 crore, operating margin against 14.45% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Arvee Laboratories share price today ahead of the Q2 earnings?
Ans. Arvee Laboratories share price is Rs 221.50 on the NSE as of 9 September 2026, up 14.33% from Rs 193.74. The stock is about 23.8% below its 52-week high of Rs 290.78 and 71.6% above its 52-week low of Rs 129.11, at a market capitalisation of Rs 244.34 crore.
Is Arvee Laboratories a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Arvee Laboratories (India) Ltd.. The stock trades at a price-to-book ratio of 7.21 with a return on equity of 7.78%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
